Home » Newsletters » BioWorld

BioWorld

April 29, 1993

View Archived Issues

EPICORE COMPLETES PRIVATE PLACEMENT

CYTOGEN RESEARCHERS WIN AWARD

STARVING TUMORS BY BLOCKING NEW BLOOD VESSELS

EPITOPE TO ISSUE WARRANTS IN SETTLEMENT

ANTICANCER GETS SBIR GRANT

ITALY APPROVES PRICE FOR THYMOSIN ALPHA 1

FDA REQUESTS COMMENTS ON FOOD LABELING

BIOTECH IS BIG BUSINESS IN MASSACHUSETTS

TEACHING CLINTON HOW TO LOVE BIOTECH

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...